CS31191A3 - Pyrimidinetrione derivatives, process of their preparation, their use and a pharmaceutical comprising them - Google Patents
Pyrimidinetrione derivatives, process of their preparation, their use and a pharmaceutical comprising them Download PDFInfo
- Publication number
- CS31191A3 CS31191A3 CS91311A CS31191A CS31191A3 CS 31191 A3 CS31191 A3 CS 31191A3 CS 91311 A CS91311 A CS 91311A CS 31191 A CS31191 A CS 31191A CS 31191 A3 CS31191 A3 CS 31191A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- compound
- iii
- group
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- SOFSSZFBVOGIKD-UHFFFAOYSA-N pyrimidine-2,4,5-trione Chemical class O=C1NC(=O)C(=O)C=N1 SOFSSZFBVOGIKD-UHFFFAOYSA-N 0.000 title claims abstract 7
- 150000001875 compounds Chemical class 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000012948 isocyanate Substances 0.000 claims description 7
- 150000002513 isocyanates Chemical class 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 239000000651 prodrug Substances 0.000 abstract description 2
- 229940002612 prodrug Drugs 0.000 abstract description 2
- FAAYXVRRJFCFOR-UHFFFAOYSA-N (2,4,5-trioxo-1,3-diazinan-1-yl)phosphonic acid Chemical class OP(O)(=O)N1CC(=O)C(=O)NC1=O FAAYXVRRJFCFOR-UHFFFAOYSA-N 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 51
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 239000000047 product Substances 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 10
- -1 3-n-butoxy-2-carbamoyloxypropyl Chemical group 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical class O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 229960005182 febarbamate Drugs 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 4
- 229960002695 phenobarbital Drugs 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- QKPIQPBNFUNZSJ-UHFFFAOYSA-N dichlorophosphorylimino(oxo)methane Chemical compound ClP(Cl)(=O)N=C=O QKPIQPBNFUNZSJ-UHFFFAOYSA-N 0.000 description 3
- QHZQILHUJDRDAI-UHFFFAOYSA-N febarbamate Chemical compound O=C1N(CC(COCCCC)OC(N)=O)C(=O)NC(=O)C1(CC)C1=CC=CC=C1 QHZQILHUJDRDAI-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- VOYADQIFGGIKAT-UHFFFAOYSA-N 1,3-dibutyl-4-hydroxy-2,6-dioxopyrimidine-5-carboximidamide Chemical compound CCCCn1c(O)c(C(N)=N)c(=O)n(CCCC)c1=O VOYADQIFGGIKAT-UHFFFAOYSA-N 0.000 description 1
- KXLGRPUTQDZSAE-UHFFFAOYSA-N 1-(3-butoxy-2-hydroxypropyl)-5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione Chemical compound O=C1N(CC(O)COCCCC)C(=O)NC(=O)C1(CC)C1=CC=CC=C1 KXLGRPUTQDZSAE-UHFFFAOYSA-N 0.000 description 1
- IZHGMMBZJWHGND-UHFFFAOYSA-N 1-butoxy-3-chloropropan-2-ol Chemical compound CCCCOCC(O)CCl IZHGMMBZJWHGND-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- ONDMKQWGMAVUNZ-UHFFFAOYSA-N butyl 2-aminoacetate Chemical compound CCCCOC(=O)CN ONDMKQWGMAVUNZ-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- FWFGVMYFCODZRD-UHFFFAOYSA-N oxidanium;hydrogen sulfate Chemical compound O.OS(O)(=O)=O FWFGVMYFCODZRD-UHFFFAOYSA-N 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- RCOUWKSZRXJXLA-UHFFFAOYSA-N propylbarbital Chemical compound CCCC1(CCC)C(=O)NC(=O)NC1=O RCOUWKSZRXJXLA-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909002890A GB9002890D0 (en) | 1990-02-08 | 1990-02-08 | Process for preparing pyrimidinetrione derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS31191A3 true CS31191A3 (en) | 1992-02-19 |
Family
ID=10670669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS91311A CS31191A3 (en) | 1990-02-08 | 1991-02-08 | Pyrimidinetrione derivatives, process of their preparation, their use and a pharmaceutical comprising them |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5262402A (zh) |
| EP (1) | EP0466887B1 (zh) |
| JP (1) | JPH04505460A (zh) |
| KR (1) | KR920701173A (zh) |
| CN (2) | CN1034806C (zh) |
| AT (1) | ATE113589T1 (zh) |
| BG (1) | BG60269B2 (zh) |
| CA (1) | CA2049991A1 (zh) |
| CS (1) | CS31191A3 (zh) |
| DE (1) | DE69104920T2 (zh) |
| DK (1) | DK0466887T3 (zh) |
| ES (1) | ES2065002T3 (zh) |
| GB (1) | GB9002890D0 (zh) |
| GE (1) | GEP19970892B (zh) |
| HR (1) | HRP950155A2 (zh) |
| HU (2) | HUT64077A (zh) |
| IE (1) | IE62606B1 (zh) |
| LT (1) | LT3316B (zh) |
| LV (1) | LV10259B (zh) |
| PL (2) | PL168051B1 (zh) |
| PT (1) | PT96694B (zh) |
| RO (1) | RO109334B1 (zh) |
| RU (1) | RU2050353C1 (zh) |
| TW (1) | TW216792B (zh) |
| WO (1) | WO1991012244A1 (zh) |
| YU (1) | YU47836B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2107064A1 (de) * | 2008-04-02 | 2009-10-07 | Basf Se | Verfahren zur Herstellung von Triamiden aus Ammoniak und Amido-Dichloriden |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2051846A (en) * | 1936-08-25 | Production of barbituric acid | ||
| US2876225A (en) * | 1959-03-03 | Manufacture of therapeutic substances | ||
| US2161212A (en) * | 1939-06-06 | Substituted barbituric acids con | ||
| US814496A (en) * | 1904-11-08 | 1906-03-06 | Firm Of E Merck | Process of making barbituric acids. |
| GB1581834A (en) | 1976-11-01 | 1980-12-31 | Sapos Sa | Complexes of barbituric acid derivatives |
| FR2424262A1 (fr) * | 1978-04-24 | 1979-11-23 | Sapos Sa | Nouveaux complexes tetrameres de derives de la malonyl-uree a action psychotrope et procede de preparation |
| GB8309813D0 (en) * | 1983-04-12 | 1983-05-18 | Sapos Sa | Pyrimidinetrione derivatives |
-
1990
- 1990-02-08 GB GB909002890A patent/GB9002890D0/en active Pending
- 1990-02-08 HU HU93285A patent/HUT64077A/hu unknown
-
1991
- 1991-02-05 CA CA002049991A patent/CA2049991A1/en not_active Abandoned
- 1991-02-05 DE DE69104920T patent/DE69104920T2/de not_active Expired - Fee Related
- 1991-02-05 TW TW080100904A patent/TW216792B/zh active
- 1991-02-05 RU SU915001934A patent/RU2050353C1/ru active
- 1991-02-05 AT AT91903577T patent/ATE113589T1/de not_active IP Right Cessation
- 1991-02-05 US US07/768,852 patent/US5262402A/en not_active Expired - Fee Related
- 1991-02-05 DK DK91903577.4T patent/DK0466887T3/da active
- 1991-02-05 RO RO148583A patent/RO109334B1/ro unknown
- 1991-02-05 PL PL91304151A patent/PL168051B1/pl unknown
- 1991-02-05 HU HU913183A patent/HU207722B/hu not_active IP Right Cessation
- 1991-02-05 ES ES91903577T patent/ES2065002T3/es not_active Expired - Lifetime
- 1991-02-05 EP EP91903577A patent/EP0466887B1/en not_active Expired - Lifetime
- 1991-02-05 PL PL91292559A patent/PL165990B1/pl unknown
- 1991-02-05 JP JP3503730A patent/JPH04505460A/ja active Pending
- 1991-02-05 WO PCT/EP1991/000253 patent/WO1991012244A1/en active IP Right Grant
- 1991-02-05 KR KR1019910701274A patent/KR920701173A/ko not_active Application Discontinuation
- 1991-02-07 YU YU21791A patent/YU47836B/sh unknown
- 1991-02-07 IE IE40991A patent/IE62606B1/en not_active IP Right Cessation
- 1991-02-07 PT PT96694A patent/PT96694B/pt not_active IP Right Cessation
- 1991-02-08 CS CS91311A patent/CS31191A3/cs unknown
- 1991-02-08 CN CN91101394A patent/CN1034806C/zh not_active Expired - Fee Related
- 1991-11-07 BG BG95434A patent/BG60269B2/xx unknown
-
1992
- 1992-12-09 LV LVP-92-273A patent/LV10259B/en unknown
-
1993
- 1993-06-03 LT LTIP612A patent/LT3316B/lt not_active IP Right Cessation
- 1993-07-27 GE GEAP19931231A patent/GEP19970892B/en unknown
-
1995
- 1995-03-28 HR HR950155A patent/HRP950155A2/xx not_active Application Discontinuation
- 1995-05-12 CN CN95106059A patent/CN1121070A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5917042A (en) | Process for the preparation of 2,5-diamino-4,6-dichloropyrimidine | |
| RU2071474C1 (ru) | Производные 4-(2-пиримидинил)-1-пиперазинила или их фармацевтически приемлемые соли | |
| EP0073328A1 (en) | Novel pyrimidine and s. triazine derivatives with antilipidemic activity | |
| KR101821847B1 (ko) | Ｎ-술포닐-치환된 옥신돌의 제조 방법 | |
| US4650892A (en) | Process for the preparation of herbicidal sulfonamides | |
| US3979408A (en) | 2-(Pyrrol-1-yl)amino-4,5-dihydro-1H-imidazole derivatives | |
| CS31191A3 (en) | Pyrimidinetrione derivatives, process of their preparation, their use and a pharmaceutical comprising them | |
| IE47232B1 (en) | Soluble derivatives of 2,4-diamino-pyrimidines | |
| CS208463B2 (en) | Method of making the 4-/n-acetyl/amino-tetrahydro-1,3,5-triazine-2,6-dions | |
| Elnagdi et al. | Reactions with cyclic amidines II. The behaviour of cyclic amidines toward ethoxycarbonyl and aroyl isothiocyanates | |
| Shutalev et al. | 4-Hydroxy-4-methyl-5-tosylhexahydropyrimidin-2-imines: synthesis and different dehydration pathways | |
| US3223729A (en) | 3-allylhydantoic acid | |
| US3957785A (en) | Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives | |
| US4066645A (en) | Derivatives of pyrazolo [1,5-a]pyrido[3,4-e]pyrimidine | |
| Kokel et al. | Reaction of N, N‐dimethylazidochloromethyleniminium chloride (azidophosgeniminium chloride) with 1, 3‐dimethyl‐4‐aminouracils. A new “one pot” synthesis of 3‐aryl‐(and 3‐alkyl)‐4, 6‐dimethyl‐5, 7‐dioxo‐1, 2, 3‐triazolo [4, 5‐d] pyrimidines (8‐azatheophyllines) via a diazo group transfer process | |
| SU576045A3 (ru) | Способ получени производных пиримидина | |
| EP0188225A1 (en) | Process for the preparation of herbicidal sulfonamides derived from substituted 2-amino-1,2,4 triazolo (1,5-a) pyrimidines and novel intermediates provided therein | |
| Elgemeie et al. | A convenient synthesis of pyrazolo [3, 4-c] pyrazoles using some novel α-cyanoketene dithioacetals | |
| JPS61205266A (ja) | ４‐アルコキシ‐６‐アルキル‐２‐シアンアミノ‐１，３，５‐トリアジン類 | |
| Khodairy | Synthesis of polyfused thieno (2, 3-b) thiophenes Part 3: Synthesis of thienopyrimidinotetrazole, thienopyrimidinotriazepine, thienopyrimidinotriazine, thienopyrimidinotriazole and pyrazolylthienopyrimidine derivatives | |
| USRE28865E (en) | Selective dehalogenation | |
| CS226949B1 (cs) | Způsob výroby substituovaných 4-Iiydroxy-5-formyíaininapyriinidinů | |
| PL216586B1 (pl) | Sposób otrzymywania nowej pochodnej 1-[(2-alkilo-2H-1,2,3-triazol-4-ilo)metylo]pirymidyno-2,4(1H,3H)-dionu | |
| AU5395900A (en) | Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists | |
| Łażewska et al. | Convenient way of synthesis and crystal structure of 1-[(5-chloro-1 H-indol-2-yl) carbonyl]-4-methylpiperazine, a histamine H4 receptor antagonist |